LIVANOVA BELGIUM
ActiveSummary
LIVANOVA BELGIUM has been active since 1968 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30.5m and a net result of €2.2m. Equity has been growing by about 10% per year since 2018. Its solvency ranks better than 84% of 6,167 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Official details
Source: KBO- Status
- Active Normal situation
- Activity
- Wholesale of pharmaceutical and medical goods NACE 46460
- Joint committees
- 100 Aanvullend Paritair Comité voor de werklieden
- 200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
- Establishment unit
- 2.148.031.247 1930 Zaventem, since 15-04-2005
- Financial year end
- 31 December
- Peppol
- Reachable since 11-11-2025
Board and ownership
- WAGNON PimManaging director
- Valeria Simona BIZZOZERODirector · since 30-06-2023
- Torrres SamuelDirector · since 21-02-2025
- Auditor
- BV PwC Bedrijfsrevisoren
- LivaNova PLCconsolidatesannual accounts 2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Turnover
- €70.3m
- ▲ 9.8%
- Profit
- €2.2m
- ▼ 31.6%
- Equity
- €30.5m
- ▲ 7.8%
- Total assets
- €38.8m
- ▲ 5.5%
- Employees on 31-12-2025
- 29
- =
- 2025 accounts filed 76 days after the deadline
Score breakdownraises riskLast filed accounts filed 76 days late; 1 of the last 3 accounts lateLiquidity: current ratio 5.66, cash €1.1m, halvedlowers riskFounded in 1968Size: turnover €70.3m, 29.2 FTE, total assets €38.8mShow the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, small). It does better than 92% of them on solvency, 59% on liquidity, 52% on profitability and 69% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 44 days before the deadline. In the sector (NACE 46), the median for financial year 2024 was 3 days before the deadline, and 39% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Appointment: PwC Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Loris Guidi
- · Gazette deed Resignation: Philippe Blancquaert (director)Appointment: Samuel Torres (director)
- · Gazette deed Permanent representatives: Loris GUIDI and Isabelle RASMONT
Comparable companies
These companies have the same main activity as LIVANOVA BELGIUM: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €16m and €61m, founded between 1964 and 1990.
| Company | Total assets | Turnover |
|---|---|---|
| LIVANOVA BELGIUM Zaventem | €38.8m | €70.3m |
| Servier Benelux Anderlecht | €61.5m | €89.1m |
| Haleon Belgium Zaventem | €29.4m | €61.8m |
| OLYMPUS BELGIUM Puurs-Sint-Amands | €36.5m | €45.4m |
| V.M.D. Arendonk | €28.5m | €40.6m |
| ABBOTT MEDICAL BELGIUM Zaventem | €40.8m | €85.5m |
| GRUNENTHAL Zaventem | €16.2m | €39.3m |
Key facts about LIVANOVA BELGIUM
- What is the company number of LIVANOVA BELGIUM?
- The company number of LIVANOVA BELGIUM is 0403.011.739. The VAT number is the same number with BE in front: BE 0403.011.739.
- Where is LIVANOVA BELGIUM based?
- The registered office is at Ikaroslaan 83, 1930 Zaventem.Company details
- What does LIVANOVA BELGIUM do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of LIVANOVA BELGIUM?
- The legal form of LIVANOVA BELGIUM is Public limited company (NV).
- When was LIVANOVA BELGIUM founded?
- LIVANOVA BELGIUM was founded on 01-01-1968.
- Is LIVANOVA BELGIUM still active?
- Yes, LIVANOVA BELGIUM is an active enterprise in the KBO register.
- How many employees does LIVANOVA BELGIUM have?
- LIVANOVA BELGIUM had an average of 29.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does LIVANOVA BELGIUM fall under?
- In its 2025 annual accounts, LIVANOVA BELGIUM states joint committees 100 (Aanvullend Paritair Comité voor de werklieden) and 200 (Aanvullend Paritair Comité voor de bedienden).
- What is the turnover of LIVANOVA BELGIUM?
- The turnover of LIVANOVA BELGIUM was €70.3m in financial year 2025, according to the filed annual accounts.
- Is LIVANOVA BELGIUM profitable?
- In financial year 2025, LIVANOVA BELGIUM made a profit of €2.2m.
- Where can I find the annual accounts of LIVANOVA BELGIUM?
- LIVANOVA BELGIUM filed 49 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of LIVANOVA BELGIUM due?
- LIVANOVA BELGIUM must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.